Cartesian Therapeutics Inc

Research Cartesian Therapeutics Inc (RNAC) on Bullrun: market cap USD 283.24M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerRNAC
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 283.24M
• Financial periodFY2025
• RevenueUSD 400.00K
• Revenue growth-99.0%
• Net income-USD 130.30M
• Free cash flow-USD 79.40M

Valuation Snapshot

latest market cap is USD 283.24M.

About Cartesian Therapeutics Inc

Cartesian Therapeutics, Inc., a clinical-stage biotechnology company, provides mRNA cell therapies for the treatment of autoimmune diseases.

Frequently asked questions

What is Cartesian Therapeutics Inc's market cap?

Cartesian Therapeutics Inc's market capitalization is USD 283.24M.

What does Cartesian Therapeutics Inc do?

Cartesian Therapeutics, Inc., a clinical-stage biotechnology company, provides mRNA cell therapies for the treatment of autoimmune diseases.